Cerity Partners LLC Has $1.02 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Cerity Partners LLC decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 15,362 shares of the company’s stock after selling 394 shares during the period. Cerity Partners LLC’s holdings in HealthEquity were worth $1,019,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Comerica Bank raised its holdings in shares of HealthEquity by 82,280.3% in the third quarter. Comerica Bank now owns 58,490 shares of the company’s stock valued at $4,273,000 after purchasing an additional 58,419 shares during the last quarter. Natixis Advisors L.P. raised its holdings in shares of HealthEquity by 7.2% in the third quarter. Natixis Advisors L.P. now owns 17,664 shares of the company’s stock valued at $1,290,000 after purchasing an additional 1,180 shares during the last quarter. Gotham Asset Management LLC purchased a new stake in shares of HealthEquity in the third quarter valued at about $1,103,000. Loomis Sayles & Co. L P raised its holdings in shares of HealthEquity by 57.8% in the third quarter. Loomis Sayles & Co. L P now owns 399,683 shares of the company’s stock valued at $29,197,000 after purchasing an additional 146,372 shares during the last quarter. Finally, American Century Companies Inc. raised its holdings in shares of HealthEquity by 23.1% in the third quarter. American Century Companies Inc. now owns 900,408 shares of the company’s stock valued at $65,775,000 after purchasing an additional 168,979 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on HQY. Royal Bank of Canada increased their price target on shares of HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Wednesday, March 20th. KeyCorp increased their price target on shares of HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, March 22nd. Barrington Research restated an “outperform” rating and set a $100.00 price target on shares of HealthEquity in a research report on Friday, March 22nd. Bank of America increased their price target on shares of HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. Finally, BTIG Research increased their price target on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and an average target price of $96.17.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $80.89 on Monday. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $6.94 billion, a PE ratio of 126.39, a P/E/G ratio of 1.32 and a beta of 0.53. HealthEquity, Inc. has a twelve month low of $48.86 and a twelve month high of $84.49. The company has a 50-day moving average price of $81.08 and a two-hundred day moving average price of $74.28.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. The firm had revenue of $262.39 million for the quarter, compared to the consensus estimate of $258.56 million. Equities analysts forecast that HealthEquity, Inc. will post 2.12 EPS for the current year.

Insider Transactions at HealthEquity

In other news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $82.59, for a total value of $211,265.22. Following the sale, the executive vice president now directly owns 47,438 shares of the company’s stock, valued at $3,917,904.42. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the sale, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Delano Ladd sold 2,558 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the completion of the sale, the executive vice president now directly owns 47,438 shares in the company, valued at $3,917,904.42. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 71,322 shares of company stock valued at $5,682,895. 2.70% of the stock is currently owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.